Heart Surgery News and Research

RSS

Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.

The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.

New set of clinical practice guidelines released to address temperature management during open heart surgery

The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology have released a set of clinical practice guidelines to address management of a patient's temperature during open heart surgery. The guidelines appear in the August issue of The Annals of Thoracic Surgery and were published simultaneously in two other journals.

30 Jul 2015

UCLA Health's hospitals named among nation's best in U.S. News and World Report

UCLA Health's hospitals in Westwood and Santa Monica have been named to U.S. News and World Report's 2015-2016 Best Hospitals Honor Roll. UCLA, which previously ranked No. 5 in the country, tied for No. 3 this year.

22 Jul 2015

UC San Diego Health ranked again among nation's best hospitals by U.S. News & World Report

Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News "Best Hospitals" rankings distinguish hospitals that excel in treating the most challenging health conditions.

21 Jul 2015

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system.

11 Jul 2015

Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

Connexient and Robert Wood Johnson University Hospital announced this week the public launch of MediNav Navigator Edition 2.0. This makes RWJUH the first hospital in North America to deliver for its patients, visitors and staff the world's first true turn-by-turn indoor navigation smartphone application, with reliable indoor positioning accuracy of one to two meters.

10 Jul 2015

UCLA patient successfully receives smaller Total Artificial Heart

A petite 44-year-old woman has received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to an experimental Total Artificial Heart designed for smaller patients.

2 Jul 2015

UCLA patient first in California to receive smaller Total Artificial Heart

A petite 44-year-old woman has received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to an experimental Total Artificial Heart designed for smaller patients.

2 Jul 2015

UCLA cardiologists use less invasive approach to replace heart valve

Last summer, after a long career as a successful entrepreneur and a brief retirement, Richard Whitaker was helping to start another new company. Unfortunately, a serious health concern caused a couple of interruptions in his work on the new venture. One of Whitaker's heart valves wasn't working properly, which caused congestive heart failure and led to two hospitalizations within several months.

2 Jul 2015

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, reveals research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Dr Carsten Wunderlich, senior consultant in the Department of Invasive Electrophysiology, Heart Centre Dresden, Germany.

25 Jun 2015

CardiAQ Valve Technologies announces first human implant of transcatheter bioprosthetic mitral heart valve

CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical transfemoral-transseptal percutaneous Transcatheter Mitral Valve Implantation (TMVI), today announced that its second-generation bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment into a 72-year-old male suffering from severe mitral regurgitation (MR 4+) with multiple co-morbidities and ineligible for alternate treatment modalities.

24 Jun 2015

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in the state of Ohio to implant a revolutionary device to treat right ventricular heart disease.

5 Jun 2015

New research draws on support from patients and public to investigate impact of cardiac surgery

A University of Leicester-based research group funded by the British Heart Foundation is drawing on support from patients and members of the public to investigate why cardiac surgery can often result in serious or fatal damage to other organs in the body.

3 Jun 2015

Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up

AF is the most common arrhythmia complicating cardiac surgery and occurs in approximately 30-40 percent of patients undergoing CABG surgery...

15 May 2015

Two physicians examine heart disease through a literary lens

Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder’s presence in great novels has remained relatively modest.

12 May 2015

Certain metabolites in the blood could predict clinical outcome in children undergoing heart surgery

The study, published today in the journal Critical Care Medicine and carried out at Royal Brompton Hospital, followed children undergoing surgery for congenital heart disease, and found that by analysing metabolites in the blood -- molecules created as a result of metabolism -- it was possible to predict a child's clinical outcome.

6 May 2015

Use of fresh whole blood from single donors may reduce complications in pediatric heart surgery patients

Using fresh whole blood from single donors is better than using component blood from multiple donors in pediatric heart surgery patients, according to an article in the May 2015 issue of The Annals of Thoracic Surgery.

30 Apr 2015

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.

10 Apr 2015

Study: Blood test can predict postoperative stroke risk following cardiac surgery

The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.

24 Mar 2015

Two-year data show continued survival advantage for self-expanding TAVR

Two-year data show a continued survival advantage for self-expanding transcatheter aortic valve replacement (TAVR) over standard surgery in high-risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

20 Mar 2015

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

Cardiovascular researchers at The Ohio State University Wexner Medical Center have shown that a protein known as MG53 is not only present in kidney cells, but necessary for the organ to repair itself after acute injury. Results from this animal model study are published in the journal Science Translational Medicine.

19 Mar 2015

Heart Surgery News and Research

New set of clinical practice guidelines released to address temperature management during open heart surgery

UCLA Health's hospitals named among nation's best in U.S. News and World Report

UC San Diego Health ranked again among nation's best hospitals by U.S. News & World Report

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

UCLA patient successfully receives smaller Total Artificial Heart

UCLA patient first in California to receive smaller Total Artificial Heart

UCLA cardiologists use less invasive approach to replace heart valve

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

CardiAQ Valve Technologies announces first human implant of transcatheter bioprosthetic mitral heart valve

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

New research draws on support from patients and public to investigate impact of cardiac surgery

Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up

Two physicians examine heart disease through a literary lens

Certain metabolites in the blood could predict clinical outcome in children undergoing heart surgery

Use of fresh whole blood from single donors may reduce complications in pediatric heart surgery patients

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Study: Blood test can predict postoperative stroke risk following cardiac surgery

Two-year data show continued survival advantage for self-expanding TAVR

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News